ID clinicians must be paid for time spent conducting unbillable work for OPAT services.
Madeline King, PharmD, BCIDP
Advertisement
King is an infectious diseases PGY2 residency program director, codirector of outpatient antimicrobial stewardship, and outpatient infectious diseases clinical pharmacist at Cooper University Hospital in Camden, New Jersey.
Articles by Madeline King, PharmD, BCIDP
Warnings and concerns regarding fluoroquinolones are on the rise, but the antibiotics still play a role, albeit more limited, in the treatment of various infectious diseases.
Advertisement
Latest Updated Articles
- Future of Fluoroquinolones: Risks, Benefits of Antibiotic Workhorse
Published: April 8th 2019 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial
2
Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections
3
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
4
Lori Handy, MD, MSCE, Discusses New Era of Dynamic, Trust-Based Health Communication
5
